T. Rowe Price Associates’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $123K | Hold |
46,942
| – | – | ﹤0.01% | 2851 |
|
|
2025
Q1 | $90K | Hold |
46,942
| – | – | ﹤0.01% | 2839 |
|
|
2024
Q4 | $69K | Buy |
46,942
+11,326
| +32% | +$16.6K | ﹤0.01% | 2881 |
|
|
2024
Q3 | $66K | Buy |
35,616
+7,504
| +27% | +$13.9K | ﹤0.01% | 2891 |
|
|
2024
Q2 | $29K | Buy |
28,112
+4,057
| +17% | +$4.19K | ﹤0.01% | 2897 |
|
|
2024
Q1 | $48K | Buy |
24,055
+700
| +3% | +$1.4K | ﹤0.01% | 2875 |
|
|
2023
Q4 | $37K | Buy |
23,355
+2,892
| +14% | +$4.58K | ﹤0.01% | 2840 |
|
|
2023
Q3 | $41K | Buy |
20,463
+1,942
| +10% | +$3.89K | ﹤0.01% | 2792 |
|
|
2023
Q2 | $59K | Buy |
+18,521
| New | +$59K | ﹤0.01% | 2779 |
|